✦ LIBER ✦

The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design

✍ Scribed by Marc Cohen; Frans Maritz; Gian Franco Gensini; Nicolas Danchin; Ari Timerman; Kurt Huber; Enrique P. Gurfinkel; Harvey White; Keith A. A. Fox; Luc Vittori; Veronique Le-Louer; Frederique Bigonzi

Book ID: 111564632
Publisher: Springer US
Year: 2000
Tongue: English
Weight: 93 KB
Volume: 10
Category: Article
ISSN: 0929-5305
DOI: 10.1023/a:1026543107533

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The safety and efficacy of subcutaneous

The safety and efficacy of subcutaneous enoxaparin vs. intravenous unfractionated heparin and tirofiban vs. placebo in the treatment of acute st-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial

✍ M Cohen; G.F Gensini; F Maritzet al 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 45 KB

The Essence Trial: Efficacy and Safety o

The Essence Trial: Efficacy and Safety of Subcutaneous Enoxaparin in Unstable Angina and Non-Q-Wave MI: A Double-Blind, Randomized, Parallel-Group, Multicenter Study Comparing Enoxaparin and Intravenous Unfractionated Heparin: Methods and Design

✍ Marc Cohen; Reginald Blaber; Christine Demers; Enrique P. Gurfinkel; Anatoly Lan 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 290 KB

The assessment of the safety and efficac

The assessment of the safety and efficacy of a new thrombolytic regimen (assent)-3 investigators. efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the assent-3 randomized trial in acute myocardial infarction

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Efficacy and safety of tenecteplase in c

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT) 3 plus randomized trial in acute myocardial infarction

✍ L. Wallentin; P. Goldstein; P.W. Armstrong 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Comparison of Efficacy and Safety of a S

Comparison of Efficacy and Safety of a Standard Versus a Loading Dose of Clopidogrel for Acute Myocardial Infarction in Patients ≥75 Years of Age (from the FAST-MI Registry)

✍ Etienne Puymirat; Nadia Aïssaoui; Pierre Coste; Gilles Dentan; Vincent Bataille; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 375 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study

✍ Ik-Kyung Jang; Veronica Pettigrew; Michael H. Picard; Peter R. Kowey; Valentin D 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 219 KB